Dr. Jay Richard McDougal, DO

Dr. McDougal practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Dr. McDougal's NPI, 1134402555, was assigned on September 21, 2011. Dr. McDougal holds Ohio license 34.010124.

Dr. McDougal's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Dr. McDougal's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Dr. McDougal is also affiliated with Marietta Memorial Hospital. The medical group on file is Camden Clark Medical Center. Dmand AI also links Dr. McDougal to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDougal practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. McDougal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. McDougal's licenses on file in 2 states: Ohio and West Virginia.

CMS data shows 983 Medicare services from Dr. McDougal across 11 procedure codes in 2024, for 269 Medicare patients. Medicare paid $53,008 for them. Every service was in an office.

CMS counts 269 Medicare patients who saw Dr. McDougal in 2024. The largest group is 75 to 84, with 107 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McDougal's median patient age at 62, with 45% women.

In 2024, Dr. McDougal wrote 6,466 Medicare Part D claims for 457 patients. 86% of them were for generic drugs. CMS names the drug for 5,778 of them, across 110 drugs with 11 or more claims each, at $651,798 in total drug cost. In 2023, CMS named 5,201 claims across 107 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. McDougal for performance year 2024, reported through an alternative payment model (APM). Dr. McDougal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McDougal as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 266 general payments to Dr. McDougal from 29 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $701.